[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hayward et al., 2003 - Google Patents

Rescue and isolation of Rb-deficient prostate epithelium by tissue recombination

Hayward et al., 2003

View PDF
Document ID
14530499786688074962
Author
Hayward S
Wang Y
Day M
Publication year
Publication venue
Cancer Cell Signaling: Methods and Protocols

External Links

Snippet

The ability to rescue viable prostate precursor tissue from Rb−/− fetal mice has allowed for the generation of Rb−/− prostate tissue and Rb−/− prostate epithelial cell lines. Herein, we provide a protocol for the rescue of urogenital precursor tissue from mouse embryos …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Jiang et al. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status
Wang et al. Embryonic signals direct the formation of tight junctional permeability barrier in the decidualizing stroma during embryo implantation
Szczyrba et al. Neuroendocrine cells of the prostate derive from the neural crest
Matsumoto et al. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis
Miliaras et al. KIT expression in fetal, normal adult, and neoplastic renal tissues
Grippo et al. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model
Manning et al. A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression
Larive et al. The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development
Brabletz et al. Generation and characterization of mice for conditional inactivation of Zeb1
Yang et al. The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer
Teuliere et al. β-catenin-dependent and-independent effects of ΔN-plakoglobin on epidermal growth and differentiation
Russo The pathobiology of breast cancer
KR20010022812A (en) Determining the transforming capability of agents
Mishra et al. Loss of cooperative function of transforming growth factor‐β signaling proteins, smad3 with embryonic liver fodrin, a β‐spectrin, in primary biliary cirrhosis
Song et al. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor β receptor type II
JP2009502159A (en) Staged expression of snails as a marker of cancer growth and disease based on DNA damage
Hayward et al. Rescue and isolation of Rb-deficient prostate epithelium by tissue recombination
US20060141454A1 (en) Use of the slug gene, or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells
US7364868B2 (en) Krüppel-like transcriptional factor KLF4/GKLF and uses thereof
Enikanolaiye et al. Involucrin–claudin-6 tail deletion mutant (CΔ206) transgenic mice: a model of delayed epidermal permeability barrier formation and repair
Joseph et al. Epithelial DNA methyltransferase-1 regulates cell survival, growth and maturation in developing prostatic buds
Bostanthirige et al. The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate
Clark-Knowles Conditional inactivation of the BRCA1 tumour suppressor gene in the mouse ovarian surface epithelium in vitro and in vivo
Khan Regulation of Phenotypic Expressions in Lung Cancer Models In Vitro and In Vivo
Weinberg Control of the Mammary Cell Cycle Clock by Estrogen and Progesterone